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Agonistic β2-adrenergic receptor autoantibodies (β2-agAAb) have been observed in sera of
patients with ocular hypertension and open-angle glaucoma (OAG). They target the β2-
receptors on trabecular meshwork, ciliary body and pericytes (Junemann et al. 2018; Hoh-
berger et al. 2019). In addition to their influence on the intraocular pressure, an association
to retinal microcirculation is discussed. This study aimed to investigate foveal avascular
zone (FAZ) characteristics by en face OCT angiography (OCT-A) in glaucoma suspects and
its relationship to β2-agAAb status in patients with OAG.
Material and methods
Thirty-four patients (28 OAG, 6 glaucoma suspects) underwent standardized, clinical exami-
nation including sensory testing as white-on-white perimetry (Octopus G1, mean defect,
MD) and structural measures as retinal nerve fibre layer (RNFL) thickness, neuroretinal rim
width (BMO-MRW), retinal ganglion cell layer (RGCL) thickness, and inner nuclear layer
(INL) thickness with high-resolution OCT. FAZ characteristics were measured by OCT-A
scans of superficial vascular plexus (SVP), intermediate capillary plexus (ICP), and deep
capillary plexus (DCP). FAZ-R was calculated (area FAZ (SVP)/area FAZ (ICP)). Using car-
diomyocyte bioassays we analysed serum samples for the presence of β2-agAAb.
Results
(I) Total mean FAZ area [mm2]: 0.34±0.16 (SVP), 0.24±0.12 (ICP), and 0.49±0.24 (DCP);
mean FAZ-R 1.58±0.94. No correlation was seen for FAZ-R with MD, RNFL, BMO-MRW,
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RGCL thickness and INL thickness (p>0.05). (II) ß2-agAAb have been observed in 91%
patients and showed no correlation with MD, RNFL, BMO-MRW, RGCL thickness and INL
thickness (p>0.05). (III) FAZ-R correlated significantly with the β2-agAAb-induced increase
of the beat rate of cardiomyocyte (p = 0.028).
Conclusion
FAZ characteristics did not correlate with any glaucoma associated functional and morpho-
metric follow-up parameter in the present cohort. However, level of β2-agAAb showed a sig-
nificantly correlation with FAZ-ratio. We conclude that β2-agAAb might be a novel
biomarker in glaucoma pathogenesis showing association to FAZ-ratio with OCT-A.
Introduction
Glaucoma is known as a multifactorial neurodegenerative disease. The exact pathomechanism
is still elusive. Thus, several factors seem to act and interact within this neurodegenerative dis-
order. Next to an increased intraocular pressure (IOP), being the main risk factor, e.g. oxida-
tive stress [1], trace elements [2], an altered trabecular meshwork [3], immunological [4] and
neuroinflammatory processes [5] are involved. In addition vascular dysregulation was seen as
pathogenetic agent [6]. It is supposed that due to an insufficient nutritive support of retinal
ganglion cells via altered microcirculation neurodegeneration could be promoted. A restricted
autoregulation with additional vasospasms may enhance this pathophysiologic changes [7].
OCT-angiography (OCT-A) offers the diagnostic option to visualize and quantify retinal
microcirculation with subsequent software tools (e.g. Erlangen Angio Tool [8]). Heidelberg
Spectralis II OCT-A (Heidelberg, Germany) is able to scan macular microcirculation in three
layers: superficial vascular plexus (SVP, thickness: 80 μm), intermediate capillary plexus (ICP,
thickness: 50μm), and deep capillary plexus (DCP, thickness: 40 μm). These layers correspond
well with anatomical structures [9]: SVP corresponds mainly to the ganglion cell layer (GCL),
ICP to the inner plexiform layer (IPL) and inner nuclear layer (INL), and DCP mainly to the
outer plexiform layer (OPL, Fig 1).
Glaucoma damage focuses on GCL loss, thus, we hypothesize that changes in retinal micro-
circulation might be accented in SVP and adjacent ICP, potentially most obvious in foveal
avascular zone characteristics (FAZ) [10]. A potential link between microvascular retinal alter-
ations and immunological findings in glaucoma might be mirrored by specific agonistic auto-
antibodies against the ß2-adrenoceptors (ß2-agAAb), as ß2-adrenoreceptors (ß2-AR) are
present on pericytes of retinal microvessels [11]. We observed these ß2-agAAb in a high per-
centage in sera of patients with primary (POAG), secondary open-angle glaucoma (SOAG) or
ocular hypertension (OHT), yet not in controls [12, 13]. The target of ß2-agAAb is additionally
present on cells of the trabecular meshwork (TM) and ciliary body [14, 15], both involved in
regulation of IOP. Thus, it is assumed that ß2-agAAb might be involved in the pathological
increase of IOP via rise of outflow resistance in the TM and increase of production of aqueous
humor in the ciliary body. The hypothesis of an increase of outflow resistance is supported by
data of Putney et al., describing an increased volume of trabecular meshwork cells in patients
with glaucoma. The altered cell volume was reportedly induced by osmotic changes due to
Na+-K+-Cl—cotransporters, activated by ß-adrenergic stimulation [16]. Clinical data of a
proof-of-principle study supported the hypothesis of a potential involvement of ß2-agAAb in
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glaucoma pathogenesis, as IOP showed a transient decrease after immunadsorption of all
immunoglobulins including ß2-agAAb [12].
The aim of the present study was to investigate foveal avascular zone (FAZ) characteristics
of SVP, ICP, and DCP by en face OCT-A in glaucoma suspects and open-angle glaucoma
patients (OAG) in relation to their corresponding β2-agAAb status.
Materials and methods
Patients
Thirty-four patients were recruited from the Department of Ophthalmology and Eye Hospital,
Friedrich-Alexander-University Erlangen-Nürnberg (Erlangen Glaucoma Registry, ISSN
2191-5008, CS-2011; NTC00494923 [17]): 6 glaucoma suspects (4 ocular hypertension, OHT;
2 pre-perimetric OAG), 28 patients with OAG. Demographic data for group and subgroups
are displayed in Table 1.
All patients underwent a standardized ophthalmological examination, which included slit-
lamp biomicroscopy, funduscopy and Goldmann applanation tonometry. Additionally, white-
on-white perimetry (Octopus 500, program G1, Interzeag, Schlieren, Switzerland; mean defect
(MD), n = 34) and measurements of the global retinal nerve fiber layer (RNFL, n = 33), Bruchs’
membrane opening—minimum rim width (BMO-MRW, n = 33), retinal ganglion cell layer
(RGCL, n = 33) and inner nuclear layer (INL, n = 33) were done (Heidelberg OCT II
Fig 1. Structure OCT detail of the macula with the corresponding structural OCT layers and OCT-A slabs of the inner retina (yellow box). Image
courtesy by Heidelberg Engineering, Heidelberg, Germany.
https://doi.org/10.1371/journal.pone.0249202.g001
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Spectralis, version 1.9.10.0, Heidelberg Engineering, Heidelberg, Germany). Diagnosis of glau-
coma suspects and POAG were based according to the criteria of the Erlangen Glaucoma reg-
istry [17]. Glaucomatous optic disc was classified after Jonas [18]. If both eyes met the
inclusion criteria, data of one eye were chosen randomly for statistical analysis. Every partici-
pant provided informed written consent. The study protocol was performed in accordance
with the tenets of the Declaration of Helsinki and was approved by the local ethics committee
of the university of Erlangen-Nürnberg.
Glaucoma suspects
Diagnosis of glaucoma suspects was based on a repeated (�2 times) increased IOP> 21
mmHg. Visual fields showed no glaucomatous scotoma. The optic disc was with (diagnosis:
pre-perimetric OAG, classified as proposed by Jonas, [18]) or without glaucomatous alter-
ations (diagnosis: OHT).
POAG
The diagnosis of POAG was based on an open anterior chamber angle. IOP had to be
increased (> 21 mmHg), repeated�2 times. The optic disc showed glaucomatous alterations
according to the classification after Jonas [18]. Visual field yielded glaucomatous scotoma
(confirmed at least once):�3 adjacent test points having a deviation� 5 dB and with one test
point with a deviation > 10 dB lower than normal or�2 adjacent test points with a
deviation� 10 dB or at least 3 adjacent test points with a deviation� 5 dB abutting the nasal
horizontal meridian or a mean visual field defect of> 2.6 dB.
Cardiomyocyte bioassay
For the functional experiments we used neonatal rat cardiomyocytes in primary culture. The
cells were prepared freshly every week with the permission 49004/19 of the Max Delbrück
Centre for Molecular Medicine. Cell culture of cardiac myocytes derived from heart ventricle
of 1–2 day-old Sprague-Dawley rats [19]. We included this information into the revised ver-
sion of the manuscript. After digestion with a 0.25% solution of crude porcine trypsin (Serva,
Germany), the cells were dispersed and suspended in a SM20-I medium (Biochrom, Ger-
many), glutamine (Serva, Germany), containing penicillin (Heyl, Germany), streptomycin
(HEFA Pharma; Germany), 10% heat-inactivated neonatal calf serum (Gibco, Germany),
hydrocortisone (Merck, Germany), and fluorodeoxyuridine (Serva, Germany). The
Table 1. Demographic data for total cohort and subdivided into glaucoma suspects and glaucoma patients: Age,
gender, intraocular pressure at the day of examination with glaucoma therapy (IOP), number of antiglaucoma-
tous eye drops, best corrected visual acuity (BCVA): Mean±SD; number family history of glaucoma, diabetes,
hypertension.
Total Glaucoma suspects Patients with OAG
Age 67.1±12.0 69.5±14.0 66.6±12.0
Gender (female/male) 16/18 2/4 14/14
IOP 15.0±3.9 13.5±2.4 15.3±4.1
Number of antiglaucomatous eye drops 1.4±1 1.7±1 1.4±1
BCVA 0.8±0.18 0.85±0.08 0.84±0.20
Family history for glaucoma 17 1 16
Diabetes 1 0 1
Hypertension 20 3 17
https://doi.org/10.1371/journal.pone.0249202.t001
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cardiomyocyte cells were seeded with a field density of 160.000 cells/cm2. The culture medium
was refaced after 24 hours. Previous to stimulation the cells were cultured for 3–4 days at
37˚C. The medium was renewed with fresh culture solution 2 hours before start of the experi-
ments. Beating rate was counted of 7–10 selected spontaneously beating cardiomyocte or syn-
chronously contracting cell clusters per flask for 15 seconds, which were placed on a heated
stage of an inverted microscope at 37˚C (cut-off < 2.0 Units, U). The cardiomyocytes were
incubated with the immunoglobulin fractions of each probands’ sera (duration: 60 min; dilu-
tion of 1:40). The change in beating rate after incubation with each probands’s sera was mea-
sured, respectively. 1 Unit (U) reflects 4 beats/min. Cutoff was 2 U.
OCT-angiography
We performed en face OCT-A measurements employing a Heidelberg OCT II Spectralis
device (Heidelberg, Germany). The OCT-A scan recorded a retinal slab of 2.9 mm x 2.9 mm
with a 15˚ angle and a lateral resolution of 5.7 μm/pixel. Data were exported and analyzed by
the Erlangen Angio-Tool (EA-Tool, Matlab; The MathWorks, Inc., R2017b) [20]. EA-Tool
used binariziation by using the Otsu thresholding algorithm [21] and Frangi vesselness filter
[22]. En face OCT-A application in combination with EA-Tool allowed analysis of FAZ area
in three different layers: superficial vascular plexus (SVP), intermediate capillary plexus (ICP),
and deep capillary plexus (DCP). We present FAZ data for SVP, ICP and DCP, respectively.
Statistical analysis
Statistical analysis was done using SPSS (version 21.0) and Excel (version 2010). The FAZ-to-
FAZ-ratio (FAZ-R) between FAZ of SVP and ICP was calculated. Data were presented by
mean ± standard deviation and percentage. T-test and correlation analysis were performed.
Results
OCT-angiography
Functional and morphometric data of Spectralis OCT II measurements are displayed in Fig 2.
OCT-A data of all patients showed a mean FAZ of 0.34±0.16 mm2 (range: 0.13 mm2–0.92
mm2) in SVP, 0.24±0.12 mm2 (range: 0.08 mm2–0.59 mm2) in ICP, and 0.49±0.24 mm2
(range: 0.18 mm2–1.09 mm2) in DCP. FAZ-R yielded a mean of 1.58±0.94.
Subgroup analysis showed a mean FAZ of 0.21±0.04 mm2 (range: 0.13 mm2–0.26 mm2) in
SVP, 0.12±0.05 mm2 (range: 0.08 mm2–0.21 mm2) in ICP, and 0.29±0.06 mm2 (range: 0.22
mm2–0.37 mm2) in DCP in glaucoma suspects. FAZ-R of glaucoma suspects yielded a mean of
1.81±0.63. Patients with OAG showed a mean FAZ of 0.36±0.17 mm2 (range: 0.17 mm2–0.92
mm2) in SVP, 0.26±0.12 mm2 (range: 0.12 mm2–0.59 mm2) in ICP, and 0.53±0.24 mm2
(range: 0.18 mm2–1.09 mm2) in DCP. Additionally, FAZ-R yielded a mean of 1.53±0.99.
No significant correlation was seen for FAZ-R with MD (p>0.05), RNF thickness (p>0.05),
BMO-MRW (p>0.05), RGC thickness (p>0.05), and INL thickness (p>0.05) for group (total
cohort) and subgroup analysis (glaucoma suspects, OAG), respectively.
β2-agAAb seropositivity
A β2-agAAb seropositivity was observed in 91% of all patients with a mean increase of beat in
comparison to the basal beating rate of 4.5±1 U (range: 2.3–7.5 U, Fig 3). Only 9% of all
patients turned out to be seronegative for β2-agAAb (<2.0 U).
Primary functional and morphometric data considering β2-agAAb seropositivity are pre-
sented in Table 2.
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β2-agAAb seropositive patients showed no correlation of β2-agAAb beat rate with MD
(p>0.05), RNF thickness (p>0.05), BMO-MRW (p>0.05), RGC thickness (p>0.05) and INL
thickness (p>0.05) for group (total cohort) and subgroup (glaucoma suspects, OAG) analysis,
respectively (Fig 4).
Considering β2-agAAb seropositivity a mean FAZ of 0.34±0.17 mm2 (range: 0.13 mm2–
0.92 mm2) was observed in β2-agAAb seropositive and 0.32±0.20 mm2 (range: 0.20 mm2–0.55
mm2) in β2-agAAb seronegative patients for the SVP layer. Data of ICP showed a mean FAZ
of 0.24±0.13 mm2 (range: 0.08 mm2–0.59 mm2) in β2-agAAb seropositive and 0.27±0.09 mm2
(range: 0.21 mm2–0.37 mm2) in β2-agAAb negative patients. FAZ of DCP was 0.48±0.22 mm2
(range: 0.18 mm2–1.09 mm2) in β2-agAAb seropositive and 0.56±0.42 mm2 (range: 0.25
mm2–1.03 mm2) in β2-agAAb negative patients. We observed a mean FAZ-R of 1.62±0.97 in
β2-agAAb seropositive and 1.13±0.31 in β2-agAAb negative patients.
A significant correlation of β2-agAAb beat rate with FAZ-R was observed (p = 0.028, Fig 5).
Discussion
Agonistic autoantibodies can be found in several diseases with a common vascular component
[19, 23–26]. β2-agAAb, able to activate the adrenergic ß2-AR have recently been reported in
patients with POAG, SOAG and even OHT, yet not in persons with healthy eyes [12, 13] Thus,
we assume that β2-agAAb is involved in the etiology glaucoma by a common mechanism. A
previous study offered an involvement of these β2-agAAb in the regulation of IOP [12]. ß2-AR
expressed on pericytes, on the cells of the ciliary body and the trabecular meshwork [14, 15]
represent potential molecular targets that cause the clinical findings. Thus, the present study
aimed to investigate a potential involvement of β2-agAAb on retinal microcirculation in
patients with glaucoma. Ninety-one percent of all patients were seropositive for ß2-agAAb,
not correlating with standard glaucoma follow-up parameters (MD, RNFL, BMO-MRW,
RGCL-, INL thickness). Analysis of FAZ in the three different macula layers yielded that
FAZ-R correlated significantly with β2-agAAb beat rate in β2-agAAb seropositive patients, yet
not with MD, RNF thickness, BMO-MRW, RGC thickness, and INL thickness.
Fig 2. Perimetric and morphometric data of total, glaucoma suspects and patients with open-angle glaucoma
(OAG): Mean defect (MD), retinal nerve fiber (RNF), Bruchs’ membrane opening—minimum rim width
(BMO-MRW), retinal ganglion cell (RGC), inner nuclear layer (INL).
https://doi.org/10.1371/journal.pone.0249202.g002
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OCT angiography is a novel diagnostic tool to visualize the retinal microcirculation of the
macula and the peripapillary region. Invasive techniques (e.g. fluorescence angiography)
required the application of dyes with potential side effects. As non-invasive method OCT-A
does not include dyes and thus offers a basis for subsequent research issues. A motion contrast
algorithm with high spatial resolution yields an improvement of the three-dimensional image of
the retinochoroidal vasculature. In the beginning retinal microvasculature could be resolved
into 2 different layers (superficial vascular plexus (SVP) and deep capillary plexus (DCP)) [27]
Fig 3. Anti-adrenergic activity β2-agAAb [U] subdivided in glaucoma suspects and glaucoma patients (raw data;
median).
https://doi.org/10.1371/journal.pone.0249202.g003
Table 2. Perimetric and morphometric data considering β2-agAAb seropositivity: Mean defect (MD), retinal
nerve fiber (RNFL), Bruchs’ membrane opening—minimum rim width (BMO-MRW), retinal ganglion cell
(RGCL), inner nuclear layer (INL).
β2-agAAb seropositive patients β2-agAAb seronegative patients
MD [dB] 3.7±4.0 4.9±7.8
RNFL [μm] 71.3±14.9 57.0±15.4
BMO-MRW [μm] 194.3±80.7 128.0±47.5
RGCL [μm] 39.6±9.9 27.7±10.0
INL [μm] 40.4±4.0 41.0±7.6
https://doi.org/10.1371/journal.pone.0249202.t002
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with current improvements up to 3 layers in the latest OCT-A tools (SVP, ICP, DCP) [28].
Experimental studies showed a good correlation of these layers with anatomical findings [9].
Spectralis II OCT-A uses a probabilistic full-spectrum amplitude decorrelation algorithm
(FSADA), reducing the signal-to-noise ratio with improvement of axial resolution (3.9 μm/
pixel) [29]. Additional implementation of projection artefact removal (PAR) tool allows analysis
of deeper retinal microvasculature without overlying artefacts. As no commercial software was
available for analysis of OCT-A images, a custom made Erlangen-Angio-Tool (EA-Tool) was
coded. EA-tool uses a Frangi’s vesselness filter for convolving [30] and an Otsu’s thresholding
algorithm for binarization of the image raw data [21]. As previous data showed an even good
reliability for the EA-Tool [20] this was the basis for its use in clinical and research settings.
Clinical studies identified an altered retinal microcirculation in a wide range of retinochor-
oidal diseases (e.g. diabetic retinopathy, vasculitis, age-related maculopathy) [31–35]. Even
glaucoma patients’ microcirculation was seen to be impaired in OCT-A imaging (see review
[36, 37]). Significantly different vessel densities were observed in glaucoma patients when
compared to healthy controls with good areas under the receiver operating characteristic
curve (AUC) [38, 39]. Interestingly, in early glaucoma diagnosis OCT-A data were hypothe-
sized to be better diagnostic tools than retinal nerve fiber layer thickness [40]. The present
study showed that especially the differences between the three retinochoroidal layers might be
Fig 4. Correlation plots of anti-adrenergic activity β2-agAAb [U] and glaucoma follow-up parameters (mean defect, MD; Bruchs’ membrane opening—
minimum rim width, BMO-MRW; inner nuclear layer, INL; retinal nerve fiber, RNF; retinal ganglion cell, RGC): We observed no significant
correlations for all presented parameters (p>0.05, Pearson’s correlation).
https://doi.org/10.1371/journal.pone.0249202.g004
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of interest in early glaucoma diagnosis. The ratio of SVP to ICP confirmed this as this FAZ-R
did not correlate with canonical glaucoma follow-up parameters (MD, RNF thickness,
BMO-MRW, RGC thickness, and INL thickness). However, it correlated with the levels of
β2-agAAb. We detected these autoantibodies in patients with early glaucoma disease or OAG
[12]. Thus, we propose that parameters (β2-agAAb, FAZ-R), which are present in very early
stages of glaucoma pathogenesis might offer a novel, early option for an extended glaucoma
diagnosis. As they correlate by each other, yet not with standard glaucoma parameters, it
might be that β2-agAAb and FAZ-R recruit a further molecular pathway, which does not influ-
ence the canonical glaucoma follow-up parameters. As we observed a correlation of FAZ ratio
with the β2-agAAb beat rate in the present study and a seropositivity of β2-agAAb even in eyes
with normal RFNL and normal RGCL (i.e. ocular hypertension) in a previous study [12], we
hypothesize that β2-agAAb are present very early in glaucoma pathogenesis and are linked to
microcirculation.
β2-agAAb are frequent. Patients with POAG and SOAG showed β2-agAAb in>78% of the
patients [13, 41] β2-agAAb “hyperactivate” the adrenergic β2-AR in various tissues (e.g. ciliary
Fig 5. Anti-adrenergic activity β2-agAAb [U] considering FAZ-ratio (cutoff 1.4; p = 0.028), plotted as raw data
and median.
https://doi.org/10.1371/journal.pone.0249202.g005
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body, and trabecular meshwork) with consecutive influence on IOP via hypersecretion of
aqueous humor and decrease of the outflow facility [12]. Activation of β2-and β3-AR on retinal
blood vessels reportedly induce vasodilatation [42, 43]. A ‘direct’ autonomic innervation is not
present in retinal blood vessels [44]. Yet, sympathetic activation can activate β2-AR ‘indirectly’
via its transmitter adrenaline [42]. Additionally, β2- and β3-AR agonists reportedly mediate
retinal vasodilatation [45]. Considering the present data available in literature, β2-AR medi-
ated vasodilation is an important factor, regulating the retinal microcirculation. To the best of
our knowledge, the exact molecular pathway mediated by β2-AR in retinal vessels is still elu-
sive. It was reported that in ischemia the behavior of β2-AR varied: whereas a subgroup was
internalized, a second group showed an alternate desensitization that finally caused an increase
in affinity [46]. This in vitro observation supports our hypothesis of a link between β2-agAAb
(via β2-AR) and impaired retinal microcirculation in glaucoma eyes. As FAZ-R significantly
correlated with β2-agAAb beat rate (p = 0.028), the present data show that the size of different
retinal microvascular layers was mutually altered in the presence of β2-agAAb and resulted in
similar FAZ sizes of both microvascular layers (Fig 6).
If the ‘lacking’ vessels are really missing or even not perfused remains unknown. The pres-
ent study suggests that β2-agAAb influence the retinal microcirculation. We hypothesize that
the influence β2-agAAb on FAZ-R is mediated by the prolonged activation of the β2-receptor.
Contrary to canonical agonists, activating the β2-receptor only for a short-term, agAAb are
known to mediate a stable and even prolonged signal. This uncontrolled hyperactivation of the
G-protein coupled receptor can result in cell-toxic effects, as observed for agAAb against
ß1AR (cardiotoxic effect) in a rat model [24]. Differences or ratios between FAZ of the distinct
microvascular layers detected in OCT-A are sensible markers for early pathogenetic alter-
ations. Retinal microcirculation should be considered a single nutritional unit. Thus, patholog-
ical alterations in one of the layers of the microvascular most likely influence the other ones.
The present study is not without limitations. Study size is small (n = 34), yet data should be
seen as having a pilot character and should be confirmed in subsequent studies. Considering
the number of subjects per group (β2-agAAb positive vs. negative), we did not make a group
comparison. Yet, statistically significant correlations between FAZ-R and β2-agAAb were
already observed in this small patient group. Furthermore, the study focused on changes of
Fig 6. FAZ of superficial vascular plexus (SVP; green; a, d), intermediate capillary plexus (ICP; yellow; b, e), and deep capillary plexus (DCP; pink; c, f) in a
β2-agAAb seronegative (a-c) and seropositive (d-f) OAG patient including a schematic sketch of the FAZ of SVP, ICP, DCP considering β2-agAAb
seropositivity.
https://doi.org/10.1371/journal.pone.0249202.g006
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FAZ in glaucoma suspects and patients with OAG taking into account the status of β2-agAAb.
Subsequent research will investigate potential alterations in vessel density of SVP, ICP and
DCP in the presence of β2-agAAb.
Conclusion
FAZ characteristics of the macula showed a significantly correlation with β2-agAAb beat rate
in glaucoma suspects and patients with open-angle glaucoma. These data support the hypothe-
sis of a pathological role of β2-agAAb in the microcirculation of the macula. Level of
β2-agAAb did not correlate with the canonical glaucoma follow-up parameters. Yet, with FAZ
characteristics, β2-agAAb should be considered a novel risk factor of glaucoma. In addition,
FAZ-R should be seen as a novel early diagnostic morphological marker of glaucoma disease.
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